Skip to main content

Table 5 Therapeutic MSCs-derived Exo-miRs in CRC treatment

From: The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer

Source of exosome

Exo-miR

Molecular target

References

Tumor-suppressive MSC-Exo-miRs

hUC-MSCs

miR-3940-5p

ITGA6

[72]

hBM-MSCs

miR-22-3p

RAP2B/PI3K/AKT pathway

[82]

hBM-MSCs

miR‐16‐5p

ITGA2

[83]

Tumorigenic MSC-Exo-miRs

hBM-MSCs

miR-424

TGFBR3

[97]

hBM-MSCs

miR-142-3p

Inhibiting the Numb expression and promoting the Notch signaling pathway

[101]

hCC-MSCs

miR-30a

miR-222

MIA3

[102]

  1. ITGA6 integrin alpha 6, ITGA2 integrin alpha 2, CRC colorectal cancer, MSCs mesenchymal stem cells, Exo-miRs exosomal microRNAs, MSC-Exo-miRs MSC-derived Exo-miRs, hCC-MSCs human CRC-derived MSCs, hUC-MSCs human umbilical cord-derived MSCs, hBM-MSCs human bone marrow-derived MSCs, MIA3 melanoma inhibitory activity protein 3, TGFBR3 transforming growth factor beta receptor 3